Novo Biosciences
Bar Harbor, US · Founded 2013 · Delaware corporation
Founders & leadership
Novo Biosciences was founded in 2013 by Kevin Strange.
KS
Kevin StrangeFounder
Board
DC
Daniel CoitBoard director
DB
Denise BarbutBoard director
Reported raises · per SEC filings
Form D private placements$4.1M disclosed across 2 rounds · 2015–2020
▶$4MraisedJun 2020 · 1 investors · BiotechnologyRule 506(b)
▶$4MraisedJun 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Viravuth YinExecutive Officer, Director
- Kevin StrangeExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $4M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75KraisedJul 2015 · 2 investors · BiotechnologyRule 506(b)
▶$75KraisedJul 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel CoitDirector
- Denise BarbutDirector
- Kevin StrangeExecutive Officer
- Offering amount
- $1M
- Amount sold
- $75K
- Minimum investment
- $25K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Novo Biosciences?
- Novo Biosciences was founded by Kevin Strange in 2013.
- How much funding has Novo Biosciences raised?
- Novo Biosciences has disclosed $4.1M raised across 2 rounds.
- Where is Novo Biosciences headquartered?
- Novo Biosciences is headquartered in Bar Harbor, US.